Browse drugs

…nts (BECs) in COPD are associated with an increased response to inhaled corticosteroid (ICS). Post-hoc analyses of randomised clinical trials of ICS-c…

…matic mothers without ICS use (n=46 no asthma vs n=25 asthma no ICS use; coefficient −0.08 /mL, 95% CI −0.01 to −0.02, p=0.012) but…

… NSW) and 1.23 (95% CI 1.19 to 1.27, Sweden) following maternal ICS use. Paternal exposures were also associated with offspring ast…

…in the severe asthma population, including those on medium-dose ICS. The findings suggest that current screening thresholds may be …

…ients with eosinophilic COPD receiving inhaled corticosteroids (ICS). However, a significant research gap exists regarding the impa…

…ophilic phenotype. These patients are most likely to respond to inhaled corticosteroids. Recent evidence supports a role for anti-eosinophilic biologic…

…er of respiratory medications; a higher proportion received any ICS (89% vs 74%), ICS+LABA (47% vs 14%), and SABA (99.5% vs 91.4%).…

…olled asthma after biologic treatment. A step-wise reduction in ICS dose was recommended in 18 publications, however, standard tape…

…eceive an anti-inflammatory reliever on discharge as part of an AIR/MART inhaler regimen.…

…rmacy was associated with gender and disease severity. LABA and ICS were the most frequently prescribed medications. As new therapi…

…en with a clinical suspicion of asthma and not yet treated with inhaled corticosteroids (ICS) were recruited to the RADicA study. An expert panel class…

…first: −0.1% (SD 0.03%) per month, p=0.001 vs AIR; and ICS plus SABA: −0.16% (SD 0.06%) per month, p=0.004, vs AIR). Therefore, regi…